CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day
The Civil Aid Service (CAS) held the Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day at the CAS Yuen Tun Camp today (September 18). The event was officiated by the District Officer (Tsuen Wan), Mr Billy Au, and the Chairman of the Tsuen Wan Rural Committee, Mr Yau Kam-ping.
Click to Gallery
CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day Source: HKSAR Government Press Releases
CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day Source: HKSAR Government Press Releases
CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day Source: HKSAR Government Press Releases
CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day Source: HKSAR Government Press Releases
CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day Source: HKSAR Government Press Releases
Located in Yuen Tun Tsuen, Tsing Lung Tau, Tsuen Wan, the history of Chung Old House can be traced back to the 1780s, when the Chung family used to live and farm in the area of Yuen Tun. In 1973, the Yuen Tung site was allocated by the Government to the CAS and has been used for training purposes since then. The Chung Old House was revitalised as a national museum in 1981, and was classified as a Grade 3 historic building in 2010. At present, the Chung Old House still possesses its original architectural features, and retains a collection of agricultural and household artefacts.
In celebration of the 75th anniversary of the founding of the People's Republic of China, the CAS held an open day for the public to visit the Chung Old House to deepen their understanding of the local history and reflect on how Chinese culture could be preserved in modern society. More than 200 Tsuen Wan residents, retired CAS members and CAS cadets participated in the event, during which the CAS Volunteer Team provided assistance.
Addressing the event, Mr Au said it is a meaningful occasion for the public not only to celebrate the National Day, but also explore the roots of the nation and learn more about its history and culture so that the tradition can be preserved and thrive. He encouraged the public to preserve and cherish the precious cultural heritage together.
Also speaking at the event, the Chief Staff Officer of the CAS, Mr Leung Kwun-hong, said the CAS Yuen Tun Camp built in 1977 has been a vital training facility and an important cradle for future CAS talent and Hong Kong society. He said that the CAS hopes to promote national spirit through the appreciation of historical buildings and cultural legacies during the Open Day.
CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day Source: HKSAR Government Press Releases
CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day Source: HKSAR Government Press Releases
CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day Source: HKSAR Government Press Releases
CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day Source: HKSAR Government Press Releases
CAS holds Celebrating the National Day and Exploring the Past: Yuen Tun Chung Old House Museum Open Day Source: HKSAR Government Press Releases
Secretary for Health chairs second meeting of Steering Committee on Health and Medical Innovation Development
The Secretary for Health, Professor Lo Chung-mau, chaired the second meeting of the Steering Committee on Health and Medical Innovation Development today (January 20) to discuss the development direction and policy initiatives for driving medical innovation in Hong Kong. Members also offered advice on the progress of establishing the Hong Kong Centre for Medical Products Regulation (CMPR) and the development of the Greater Bay Area International Clinical Trial Institute (GBAICTI).
At the meeting, members were briefed on the latest developments of establishing the CMPR. Since its establishment in June last year, the Preparatory Office for the CMPR has been taking forward a number of measures, including reviewing the regulatory work of drugs and medical devices in other regions to formulate a regulatory framework of drugs and medical devices suitable for Hong Kong, assessing the need for legislation, devising the restructuring of the existing regulatory functions and service plans for drugs and medical devices, and proposing the timetable for the establishment of the CMPR and the roadmap towards the adoption of "primary evaluation" in the first half of this year.
Furthermore, members also offered advice on the strategic development plan for the GBAICTI. The GBAICTI will take forward a number of key tasks this year, including promoting process optimisation, establishing a one-stop Hong Kong Clinical Trial Digital Portal, strengthening collaboration within the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), and planning for the GBAICTI's move into one of the wet laboratory-enabled buildings at the soon-to-be-completed Hong Kong-Shenzhen Innovation and Technology Park, with a view to further enhancing Hong Kong's overall clinical trial efficiency and capability.
Other key areas of work of the GBAICTI include talent training, strengthening Hong Kong's role in regional and international clinical trial networks, and establishing a high-level international clinical trial services platform in collaboration with other GBA cities, with a view to pushing ahead with the development of an advanced biomedical industry at full steam by capitalising on Hong Kong's unique advantages of enjoying strong support of the motherland and being closely connected to the world, thereby complementing the development goals as set out in the Development Plan for Shenzhen Park of Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone promulgated by the State Council.
Professor Lo said, "At today's meeting, members of the Steering Committee recognised the efforts of the Hong Kong Special Administrative Region (HKSAR) Government in promoting health and medical innovation and offered professional advice on the way forward regarding the development direction and policy initiatives. The Health Bureau (HHB) will actively follow up, and make every effort to take forward and implement the measures on expediting the reform of the approval mechanism for drugs and medical devices and enhancing Hong Kong's clinical trial capability on all fronts as set out in 'The Chief Executive’s 2024 Policy Address' by complementing technological innovation with institutional innovation. The HHB will also collaborate with Shenzhen to establish the GBA Clinical Trial Collaboration Platform to extend the research and development (R&D) network and expedite clinical trials; and establish the Real-World Study and Application Centre to leverage Hong Kong's vast and standardised high-quality medical databases, with a view to accelerating Hong Kong's development into an international health and medical innovation hub."
"In the Resolution of the Communist Party of China (CPC) Central Committee on Further Deepening Reform Comprehensively to Advance Chinese Modernization adopted by the Third Plenary Session of the 20th CPC Central Committee, it mentions the development strategy for further reforming the medical and healthcare systems and improving the mechanisms for supporting the development of innovative drugs and medical equipment. The HHB will embrace changes while staying principled, and leverage Hong Kong's advantages of 'one country, two systems', its high-quality healthcare professions and high compatibility with international standards and more, to develop Hong Kong into an international health and medical innovation hub and foster co-ordinated development with other GBA cities, so that patients may benefit from the most advanced diagnostic and treatment technologies, thereby achieving the goal of bringing the benefits of good drugs and R&D to Hong Kong. At the same time, we will promote the development of advanced biomedical technology industries and actively integrate into the overall national development by showing support for fostering new quality productive forces in biomedical technology as set out in the Resolution and the Development Plan to align with national development strategies," he emphasised.
Established and wholly owned by the HKSAR Government, the GBAICTI officially opened on November 21 last year in the Hong Kong Park of the Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone. The GBAICTI co-ordinates clinical trial resources in the public and private sectors in Hong Kong and serve as a one-stop clinical trial support platform for medical research institutions. The Greater Bay Area International Clinical Trials Center in the Shenzhen Park also officially opened on the same day. The "one institute, one center" will jointly establish the GBA Clinical Trial Collaboration Platform under the "one zone, two parks" co-ordinated development model.
Secretary for Health chairs second meeting of Steering Committee on Health and Medical Innovation Development Source: HKSAR Government Press Releases
Secretary for Health chairs second meeting of Steering Committee on Health and Medical Innovation Development Source: HKSAR Government Press Releases